Literature DB >> 4823478

Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.

A M Steward, D Nixon, N Zamcheck, A Aisenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4823478     DOI： 10.1002/1097-0142(197405)33:5<1246::aid-cncr2820330509>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  36 in total

Review 1.  The next wave of recombinant and synthetic anticancer vaccines.

Authors:  K R Irvine; N P Restifo
Journal:  Semin Cancer Biol       Date:  1995-12       Impact factor: 15.707

2.  Serum tumor marker kinetics and the clinical course of patients with advanced breast cancer.

Authors:  H Sonoo; J Kurebayashi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas.

Authors:  Megan C Duggan; Caroline Jochems; Renee N Donahue; Jacob Richards; Volodymyr Karpa; Elizabeth Foust; Bonnie Paul; Taylor Brooks; Susheela Tridandapani; Thomas Olencki; Xueliang Pan; Gregory B Lesinski; Jeffrey Schlom; William E Carson Iii
Journal:  Cancer Immunol Immunother       Date:  2016-08-31       Impact factor: 6.968

4.  Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.

Authors:  Benjamin Cahan; Lucille Leong; Lawrence Wagman; David Yamauchi; Stephen Shibata; Sharon Wilzcynski; Lawrence E Williams; Paul Yazaki; David Colcher; Paul Frankel; Anna Wu; Andrew Raubitschek; John Shively; Jeffrey Y C Wong
Journal:  Cancer Biother Radiopharm       Date:  2017-09       Impact factor: 3.099

5.  [Diagnostic validity of CEA determination in metastasizing breast cancer].

Authors:  G Krieger; M Prangen; R Klar; M Kneba; G Bandlow; G A Nagel
Journal:  Klin Wochenschr       Date:  1986-08-01

Review 6.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Evaluation of follow-up methods to detect relapse after mastectomy in breast cancer patients.

Authors:  B Cantwell; J J Fennelly; M Jones
Journal:  Ir J Med Sci       Date:  1982-01       Impact factor: 1.568

8.  Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.

Authors:  K Irvine; J Schlom
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

9.  Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer.

Authors:  C C Zielinski; I Stuller; P Rausch; C Müller
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

10.  Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients.

Authors:  Y Kitsukawa
Journal:  Jpn J Surg       Date:  1979-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.